Bivalirudin versus Heparin in Primary Percutaneous Coronary Intervention- a Meta analysis

被引：0

作者：

Narayanan, Mahesh Anantha ^{[1
]}

Reddy, Yogesh N. V. ^{[2
]}

Anugula, Dixitha ^{[3
]}

Gujjula, Nagarjuna ^{[3
]}

Badheka, Apurva ^{[4
]}

Deshmukh, Abhishek ^{[2
]}

Kaushik, Manu ^{[5
]}

Raveendran, Ganesh ^{[6
]}

机构：

[1] Univ Minnesota, Roseville, MN USA

[2] Mayo Clin, Rochester, MN USA

[3] Creighton Univ, Med Ctr, CHI Hlth, Omaha, NE USA

[4] Everett Clin, Everett, WA USA

[5] NWI VA Med Ctr, Omaha, NE USA

[6] Univ Minnesota, St Paul, MN 55108 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 68卷 / 18期

关键词：

D O I：

10.1016/j.jacc.2016.09.298

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

TCT-156

引用

页码：B64 / B64

页数：1

共 50 条

[31] BIVALIRUDIN VERSUS HEPARIN MONOTHERAPY IN PERCUTANEOUS CORONARY INTERVENTION PATIENTS: AN ANALYSIS OF ACUTE ADVERSE OUTCOMES AND COST [J].

Ephrem, Georges ;

Guenoun, Jonathan ;

Kim, Michael ;

Jauhar, Rajiv ;

Meraj, Perwaiz .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) :A115-A115

[32] Bivalirudin Versus Heparin During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction [J].

Patel, Hitcn ;

Garris, Rana ;

Bhutani, Suchit ;

Shah, Priyank ;

Rampal, Upamanyu ;

Vasudev, Rahul ;

Melki, Gabriel ;

Abu Ghalyoun, Bader ;

Virk, Hartaj ;

Bikkina, Mahesh ;

Shamoon, Faycz .

CARDIOLOGY RESEARCH, 2019, 10 (05) :278-284

[33] Efficacy of Bivalirudin versus Heparin Use on Clinical Outcomes Post Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [J].

Jaiswal, Vikash ;

Jaiswal, Akash ;

Saleeb, Marina ;

Jha, Mayank ;

Arora, Ananya ;

Gupta, Shiva ;

Evbayekha, Endurance O. ;

Taha, Amira Mohamed ;

Ang, Song Peng ;

Grubb, Kendra J. .

CIRCULATION, 2023, 148

[34] Bivalirudin versus heparin in percurtaneous coronary interventions: A meta-analysis [J].

Ebrahimi, R ;

Lincoff, AM ;

Shah, AP ;

Bittl, JA ;

Chew, D ;

Wolski, K .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) :36A-37A

[35] Heparin Versus Bivalirudin for Non-Primary Percutaneous Coronary Intervention: A Post-Hoc Analysis of the CPORT-E Trial [J].

Czarny, Matthew J. ;

Hwang, Chao-Wei ;

Naiman, Daniel Q. ;

Lemmon, Cynthia C. ;

Hasan, Rani K. ;

Wang, Thomas ;

Aversano, Thomas .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2017, 90 (03) :366-377

[36] Heparin, bivalirudin, and reduction of complications during percutaneous coronary intervention [J].

Nappi, J .

PHARMACOTHERAPY, 2002, 22 (06) :89S-89S

[37] Meta-analysis of bivalirudin versus heparin in transradial coronary interventions [J].

Kheiri, Babikir ;

Rao, Sunil V. ;

Osman, Mohammed ;

Simpson, Timothy F. ;

Barbarawi, Mahmoud ;

Zayed, Yazan ;

Dhillon, Harsukh N. ;

Alkhouli, Mohamad ;

Golwala, Harsh ;

Zahr, Firas ;

Bhatt, Deepak L. ;

Stone, Gregg W. ;

Cigarroa, Joaquin E. .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 96 (06) :1240-1248

[38] Bivalirudin or Heparin for Percutaneous Coronary Intervention: Which One to Choose? [J].

Habib, Muzzamal ;

Khan, M. F. ;

Carrozza, Joseph P., Jr. .

CIRCULATION, 2009, 120 (18) :S934-S934

[39] Bivalirudin vs. heparin in planned percutaneous coronary intervention [J].

Taylor, Jennifer .

EUROPEAN HEART JOURNAL, 2014, 35 (47) :3320-3320

[40] Cost minimization analysis of bivalirudin versus heparin plus planned abxicimab in patients undergoing percutaneous coronary intervention [J].

Cequier, A. ;

Moris, C. ;

Badia, X. ;

Lara, N. .

VALUE IN HEALTH, 2006, 9 (06) :A348-A349

← 1 2 3 4 5 →